192 related articles for article (PubMed ID: 11816843)
21. Imatinib. Novartis.
Radford IR
Curr Opin Investig Drugs; 2002 Mar; 3(3):492-9. PubMed ID: 12054102
[TBL] [Abstract][Full Text] [Related]
22. A comparative assessment of the risks and benefits of zopiclone: a review of 15 years' clinical experience.
Hajak G
Drug Saf; 1999 Dec; 21(6):457-69. PubMed ID: 10612270
[TBL] [Abstract][Full Text] [Related]
23. [Zopiclone. Data of experimental pharmacology and clinical use].
Stutzmann JM; Delahaye C; Allain H
Therapie; 1993; 48(1):33-42. PubMed ID: 8356543
[TBL] [Abstract][Full Text] [Related]
24. Pharmacologic management of insomnia.
Walsh JK
J Clin Psychiatry; 2004; 65 Suppl 16():41-5. PubMed ID: 15575804
[TBL] [Abstract][Full Text] [Related]
25. Eszopiclone: an update on its use in insomnia.
Owen RT
Drugs Today (Barc); 2011 Apr; 47(4):263-75. PubMed ID: 21573250
[TBL] [Abstract][Full Text] [Related]
26. Eszopiclone for insomnia.
Melton ST; Wood JM; Kirkwood CK
Ann Pharmacother; 2005 Oct; 39(10):1659-66. PubMed ID: 16131537
[TBL] [Abstract][Full Text] [Related]
27. Zopiclone in clinical practice.
Int Clin Psychopharmacol; 1990 Apr; 5 Suppl 2():1-158. PubMed ID: 2387980
[No Abstract] [Full Text] [Related]
28. Pharmacological studies on zopiclone.
Julou L; Bardone MC; Blanchard JC; Garret C; Stutzmann JM
Int Pharmacopsychiatry; 1982; 17 Suppl 2():46-58. PubMed ID: 6145682
[TBL] [Abstract][Full Text] [Related]
29. Zopiclone. A review of its pharmacological properties and therapeutic efficacy as an hypnotic.
Wadworth AN; McTavish D
Drugs Aging; 1993; 3(5):441-59. PubMed ID: 8241608
[TBL] [Abstract][Full Text] [Related]
30. Abetimus (La Jolla pharmaceuticals).
Lorenz HM
Curr Opin Investig Drugs; 2002 Feb; 3(2):234-9. PubMed ID: 12020052
[TBL] [Abstract][Full Text] [Related]
31. Daytime functioning in older patients suffering from chronic insomnia: treatment outcome in a randomized controlled trial comparing CBT with Zopiclone.
Omvik S; Sivertsen B; Pallesen S; Bjorvatn B; Havik OE; Nordhus IH
Behav Res Ther; 2008 May; 46(5):623-41. PubMed ID: 18417099
[TBL] [Abstract][Full Text] [Related]
32. Eszopiclone (Lunesta), a new hypnotic.
Med Lett Drugs Ther; 2005 Feb; 47(1203):17-9. PubMed ID: 15767972
[TBL] [Abstract][Full Text] [Related]
33. Insomnia. Diagnosis and management.
Grunstein R
Aust Fam Physician; 2002 Nov; 31(11):995-1000. PubMed ID: 12471955
[TBL] [Abstract][Full Text] [Related]
34. Zopiclone and sleep research.
Sleep; 1987; 10 Suppl 1():1-87. PubMed ID: 3438643
[No Abstract] [Full Text] [Related]
35. [Zopiclone dependence. Report of one case].
Pallavicini J; Acevedo X
Rev Med Chil; 1997 Mar; 125(3):336-40. PubMed ID: 9460272
[TBL] [Abstract][Full Text] [Related]
36. Remune. Immune Response.
Lai D; Jones T
Curr Opin Investig Drugs; 2002 Mar; 3(3):391-8. PubMed ID: 12054085
[TBL] [Abstract][Full Text] [Related]
37. Deramciclane (Egis).
Kõks S; Vasar E
Curr Opin Investig Drugs; 2002 Feb; 3(2):289-94. PubMed ID: 12020062
[TBL] [Abstract][Full Text] [Related]
38. Flavopiridol. National Cancer Institute.
Wang HK
Curr Opin Investig Drugs; 2001 Aug; 2(8):1149-55. PubMed ID: 11892928
[TBL] [Abstract][Full Text] [Related]
39. Dependence on zopiclone.
Flynn A; Cox D
Addiction; 2006 Jun; 101(6):898. PubMed ID: 16696635
[No Abstract] [Full Text] [Related]
40. Misuse of zopiclone and convulsions during withdrawal.
Aranko K; Henriksson M; Hublin C; Seppäläinen AM
Pharmacopsychiatry; 1991 Jul; 24(4):138-40. PubMed ID: 1754610
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
